NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,732 | +0.9% | 17 | 0.0% | 0.00% | – |
| Q2 2023 | $1,716 | +9.7% | 17 | 0.0% | 0.00% | – |
| Q1 2023 | $1,564 | -94.6% | 17 | -94.6% | 0.00% | -100.0% |
| Q4 2022 | $28,758 | +19.8% | 317 | 0.0% | 0.01% | +12.5% |
| Q3 2022 | $24,000 | -22.6% | 317 | -13.2% | 0.01% | -11.1% |
| Q2 2022 | $31,000 | -3.1% | 365 | 0.0% | 0.01% | +28.6% |
| Q1 2022 | $32,000 | +23.1% | 365 | +21.7% | 0.01% | +40.0% |
| Q4 2021 | $26,000 | +4.0% | 300 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $25,000 | -7.4% | 300 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $27,000 | +3.8% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $26,000 | -7.1% | 300 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $28,000 | +7.7% | 300 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $26,000 | -44.7% | 300 | -44.5% | 0.01% | -53.3% |
| Q2 2020 | $47,000 | +88.0% | 541 | +80.3% | 0.02% | +50.0% |
| Q1 2020 | $25,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |